Reimbursed with a limitationGenericATC B01AC24

Ticagrelor NOBEL

Ticagrelor NOBEL is a generic from NOBEL Pharma Schweiz AG and is listed on the FOPH Specialities List. Basic health insurance reimburses it within the authorised indication. The public price ranges from CHF 38.70 to CHF 93.75 depending on the pack; the co-payment is 10 per cent.

Core data

Authorisation holder
NOBEL Pharma Schweiz AG
ATC code
B01AC24
IT group
06.03.20 Thrombozytenaggregationshemmer
Active substances
Ticagrelorum
Preparation type
Generic
On the SL since
01/12/2024
Last price change
01/12/2024
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Ticagrelor NOBEL Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Filmtabl 60 mgBlist 56 StkCHF 20.48CHF 38.7001/12/2024B7680692940018
Filmtabl 60 mgBlist 168 StkCHF 61.43CHF 83.2001/12/2024B7680692940025
Filmtabl 90 mgBlist 56 StkCHF 23.70CHF 42.2001/12/2024B7680692940032
Filmtabl 90 mgBlist 98 StkCHF 41.47CHF 61.5501/12/2024B7680692940056
Filmtabl 90 mgBlist 168 StkCHF 71.10CHF 93.7501/12/2024B7680692940049

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingIndication 21870.01Valid from 01/12/2024

In Kombination mit Acetylsalicylsäure (ASS) zur Prävention thrombotischer Ereignisse (kardiovaskulärer Tod, Myokardinfarkt, Schlaganfall) bei Patienten mit anamnestisch bekanntem Myokardinfarkt, der mindestens 12 Monate und nicht länger als 2 Jahre zurückliegt, oder bei denen eine allfällige Unterbrechung der dualen Thrombozytenaggregationshemmung nicht länger als 1 Jahr dauerte. Zusätzlich müssen diese Patienten mindestens einen weiteren kardiovaskulären Risikofaktor (zweiter vorangegangener Myokardinfarkt; koronare Mehrgefässerkrankung; Diabetes mellitus, der eine Medikation erfordert; Alter ≥65 Jahre und/oder chronische nichtterminale Niereninsuffizienz) aufweisen.

Die erweiterte Behandlung mit Ticagrelor über 3 Jahre hinaus bedarf einer erneuten Evaluierung des Nutzen-Risiko-Profils des Patienten.

FOPH wordingIndication 21870.01Valid from 01/12/2024

In Kombination mit Acetylsalicylsäure (ASS) zur Prävention thrombotischer Ereignisse (kardiovaskulärer Tod, Myokardinfarkt und Schlaganfall) bei Patienten mit akutem Koronarsyndrom (instabile Angina pectoris (UA), Myokardinfarkt ohne ST-Streckenhebung (NSTEMI) bzw. mit ST-Streckenhebung (STEMI)); für Patienten unter medikamentöser Therapie sowie für solche, die mittels perkutaner Koronarintervention (PCI) oder koronarer Bypassoperation (CABG) behandelt werden.
Die maximale Anwendungsdauer von Ticagrelor beträgt 12 Monate.

More preparations in this group

FAQ

Is Ticagrelor NOBEL covered by Swiss health insurance?

Yes, but only under conditions. Ticagrelor NOBEL is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Ticagrelor NOBEL cost in Switzerland?

The public price is the maximum price set by the FOPH and for Ticagrelor NOBEL ranges from CHF 38.70 to CHF 93.75 per pack. The ex-factory price ranges from CHF 20.48 to CHF 71.10. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com